January 20, 2015 | The Israeli company providing contact-free patient monitoring, EarlySense, announced that it completed a $20 million financing round. The round was led by Samsung Ventures, which invested $10 million of the amount, along with Pitango Venture Capital, Welch Allyn, JK&B, Proseed and Noaber. EarlySense is a medical device company based in Ramat Gan, Israel that develops patient monitoring systems. The company is currently headed by CEO Avner Halperin.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments